Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Singular Health Group Ltd ( (AU:SHG) ) has provided an announcement.
Singular Health Group Limited has raised $344,000 through the exercise of 1,720,000 unlisted options at $0.20 each, resulting in the issuance of an equivalent number of fully paid ordinary shares. The newly issued shares will be subject to a 12‑month voluntary escrow period, and the company has confirmed compliance with relevant Corporations Act disclosure and reporting obligations, signalling a modest capital injection while maintaining regulatory transparency for shareholders.
The most recent analyst rating on (AU:SHG) stock is a Hold with a A$0.24 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.
More about Singular Health Group Ltd
Singular Health Group Limited is a Western Australian, ASX-listed medical technology company focused on creating an integrated healthcare ecosystem that unlocks the full value of medical imaging records. Its core 3Dicom software solutions enable patients and practitioners to better visualise, communicate and understand medical imaging data, with its 3Dicom MD product cleared for diagnostic use in the United States, positioning the company in the advanced medical imaging and healthtech software market.
Average Trading Volume: 421,662
Technical Sentiment Signal: Buy
Current Market Cap: A$81.63M
Find detailed analytics on SHG stock on TipRanks’ Stock Analysis page.